Development and immunological evaluation of SARS-CoV-2 virus-like particles (VLP) expressing the prefusion stabilized variants of the Spike protein

Download

index.pdf

Date

2022-1-24

Author

İpekoğlu, Emre Mert

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

383
views

828
downloads

Emergence of the COVID-19 pandemic necessitated rapid development of highly effective vaccines against SARS-CoV-2. One adaptable strategy to produce a vaccine candidate against SARS-CoV-2 is based on the exploitation of the self- assembly feature of the structural proteins of SARS-CoV-2: Spike, Membrane, Envelope and Nucleocapsid, forming Virus-like particles (VLP). Our early studies focused on laboratory-scale production of SARS-CoV-2 VLPs in a mammalian host cell system based on transient expression of viral proteins. Herein, we describe a process development framework for scalable production and purification of SARS- CoV-2 VLPs expressing either the prefusion stabilized (2p) or the thermostable six proline (6p; HexaPro) stabilized Spike proteins. Results showed that suspension culture-adapted HEK 293 cells were able to produce vesicular VLPs that were similar in size to the authentic SARS-CoV-2 virions. Combined use of multimodal chromatography, nucleic acid removal through Denarase treatment and tangential flow filtration,enabled large-scale production of the SARS-CoV-2 VLPs. v In this study, we also produced and affinity purified 6x histidine-tagged recombinant Spike (6p) protein of SARS-CoV-2 to conduct in-house serological assays to monitor VLP vaccine-induced anti-Spike immunoglobulin response in immunized mice. Our results demonstrated that a modified purification protocol was superior to conventional affinity purification technique for the production of the secreted recombinant protein in terms of reproducibility and standardization of ELISA experiments. Finally, we examined the immunogenicity of 2p and 6p Spike harbouring VLPs combined with vaccine adjuvants K3 CpG ODN and/or Alum. Collectively, our results suggest that Alum adsorbed, K3 CpG adjuvanted high dose 6p VLPs elicited robust humoral and cellular immune responses in vaccinated BALB/c mice as compared to non-adjuvanted, low dose or 2p VLP counterparts, proving the effectiveness of this formulation as a vaccine candidate against SARS-CoV-2.

Subject Keywords

SARS-CoV-2, Virus-like particles, Vaccine, K3 CpG ODN, COVID-19

URI

https://hdl.handle.net/11511/96233

Collections

Graduate School of Natural and Applied Sciences, Thesis

Suggestions

OpenMETU
Core

PRODUCTION OF VIRUS LIKE PARTICLES EXPRESSING ALPHA (B.1.1.7) OR DELTA PLUS (B.1.617.2.1) SPIKE VARIANTS AND DEVELOPMENT OF A PSEUDOTYPED VIRUS NEUTRALIZATION ASSAY Güvençli, Neşe; Gürsel, Mayda; Department of Molecular Biology and Genetics (2022-2-10) Vaccines are one of the most important public health interventions to combat the spread of infectious diseases. All currently approved COVID-19 vaccines target Spike antigen derived from the authentic Wuhan strain. However, with the emergence of new variants effectiveness of the current vaccines declined, commensurate to their ability to generate neutralizing antibodies against some variants of concern (VOC). Since new VOCs are predicted to emerge the next 2-4 years, variant specific vaccines are urgently n...
Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice Özcengiz, Erkan; Keser, Duygu; Özcengiz, Gülay; Çelik, Gözde; ÖZKUL, AYKUT; İnçeh, Fatma Nur (2022-12-01) Coronavirus disease (COVID-19) is ongoing as a global epidemic and there is still a need to develop much safer and more effective new vaccines that can also be easily adapted to important variants of the pathogen. In the present study in this direction, we developed a new COVID-19 vaccine, composed of two critical antigenic fragments of the S1 and S2 region of severe acute respiratory syndrome coronavirus 2 as well as the whole nucleocapsid protein (N), which was formulated with either alum or alum plus mon...
An analysis of the incidence of measles in Turkey since 1960 Caliskan, Deniz; Piyal, Birgul; Akdur, Recep; Ocaktan, Mine Esin; Yozgatlıgil, Ceylan (2016-01-01) Background/aim: The aims of this study were to evaluate measles incidence and the effect of elimination strategy interventions on the disease from 1960 to 2014 in Turkey. The administration of measles vaccine started in the rural regions in 1970; it was carried out as a campaign along with the National Vaccine Campaign in 1985, and it has been employed as combined measles, mumps, and rubella under the scope of the Measles Elimination Program (MEP) since 2006 in Turkey. While a dramatic decrease in the repor...
Analysis of threshold dynamics of epidemic models in a periodic environment Evcin, Cansu; Uğur, Ömür; Department of Scientific Computing (2013) Threshold dynamics used to control the spread of the disease in infectious disease phenomena has an overwhelming importance and interest in mathematical epidemiology. One of the famous threshold quantity is known to be the basic reproduction ratio. Its formulation as well as computation is the main concern of infectious diseases. The aim of this thesis is to analyze the basic reproduction ratio in both autonomous and periodic systems via defining R0 as the spectral radius of the next generation operator. Th...
Assessment of the immunogenicity and formulation of recombinant proteins from SARS-CoV-2 as vaccine antigens Keser, Duygu; Özcengiz, Gülay; Department of Biology (2022-9-15) COVID-19 is an infectious disease caused by SARS-CoV-2. The virus was first detected in Wuhan, China in late 2019, and the outbreak was declared a pandemic in January 2020 by WHO, and continues to spread worldwide. As of July 2022, more than 575 million confirmed cases have been detected all over the world, and more than 6 million people died from the disease. One of the most important public health measures in combating the spread of infectious diseases is vaccination. Despite the existence of rapidly deve...

Citation Formats

E. M. İpekoğlu, “Development and immunological evaluation of SARS-CoV-2 virus-like particles (VLP) expressing the prefusion stabilized variants of the Spike protein,” M.S. - Master of Science, Middle East Technical University, 2022.